VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 0957367
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left-sided tender supraclavicular lymph node; This is a spontaneous report from a contactable Physician(patient). This 40-year-old female patient (not pregnant) received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EK4176), intramuscular at left arm on 09Jan2021 09:15 at single dose for covid-19 immunisation. Medical history included Eosinophilic Esophagitis, chronic constipation, allergy to tree nuts. Concomitant medication included macrogol 3350 (MIRALAX). Patient previously received first dose BNT162B2 (Lot number: EH9899) intramuscular at left arm on 19Dec2020 14:30 at single dose for covid-19 immunisation. The patient experienced Left-sided tender supraclavicular lymph node developed the morning after 2nd dose of COVID vaccine on 10Jan2021 06:30 with outcome of recovering. No treatment was received. There was no other vaccine in four weeks, no covid prior vaccination, covid tested post vaccination. Event was non-serious.

Other Meds: MIRALAX

Current Illness:

ID: 0957369
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle pain throughout torso; Sore throat; Head ache that comes and goes; This is a spontaneous report from a contactable consumer reporting for herself. A 63-year-old female patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EL3246), via an unspecified route of administration, on 06Jan2021 at 12:00 AM, at single dose, for COVID-19 immunisation. Medical history included allergy to some antibiotics. Concomitant medications were not reported. Patient did not have COVID-19 prior to vaccination. The patient experienced muscle pain throughout torso, sore throat and head ache that comes and goes all on 09Jan2021 at 07:00 PM with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test (nasal swab): negative on 07Jan2021.

Other Meds:

Current Illness:

ID: 0957370
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dose Number:1/ Date of start of drug: 21Dec2020/ Dose Number:2/ Date of start of drug: 08Jan2021; Mild fever; Nausea; Headache; Pain in the muscles and joints; Pain in the muscles and joints; This is a spontaneous report from a contactable consumer reporting for her sister. A 40-years-old female patient received the second dose of bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on 08Jan2021 at single dose for COVID 19 immunization via an unspecified route of administration from 21Dec2020 to 21Dec2020 at SINGLE DOSE for an unspecified indication . The patient medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 21Dec2020. On 08Jan2021 about 12 hours after the administration of the vaccine, the patient experienced mild fever, nausea, headache, pain in the muscles and joints. The outcome of all the reported events was recovering. The patient received the second dose before the day 21. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957371
Sex: F
Age:
State: CT

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever night sweats; Fever night sweats; severe anxiety from 12 am -5 am, anxiety subsiding; weakness; muscle pain; Dizziness; Now having swelling lymph nodes under left arm; pain down entirety of the arm; This is a spontaneous report from a contactable other health care rofessional (HCP) (Patient). A 33-year-old female patient not pregnant received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Intramuscular Left arm on 07Jan2021 02:00 PM at a single dose for COVID-19 immunization, Lot number: unknown. Medical history was reported as none. Patient had no known allergies. Concomitant medications were not provided. First vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Dec2020 02:00 PM Intramuscular Left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if patient received any other vaccine within four weeks prior to the vaccination. Patient had not been tested for COVID-19 post vaccination. The patient received purified protein derivative (PPD) within two weeks prior to the vaccination on unknown date in Jan2021 (reported as last week), unknown results. On 08Jan2021 12:00 AM patient experienced fever night sweats, severe anxiety from 12 am -5 am, anxiety subsiding, residual fever, weakness, muscle pain and dizziness for the next 48 hours. Now having swelling lymph nodes under left arm and pain down entirety of the arm. No treatment received for the events. At the time of the report anxiety was recovering and patient had not recovered from the other mentioned events. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0957372
Sex: F
Age:
State: CT

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Headache; Dose number 1: 17Dec2020/dose number 2: 04Jan2021; This is a spontaneous report from a contactable physician (patient). A 45-years-old female patient received second dose of bnt162b2 (BNT162B2, lot number=EK9231), via an unspecified route of administration on 04Jan2021 on Left arm at single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient previously received COVID 19 (Pfizer), lot number=EK5730, administration date=17Dec2020, administration time=04:15 PM, administrator route=Intramuscular, vaccine location=Left arm, dose number=1. The patient received second dose of bnt162b2 on 04Jan2021, experienced fatigue and headache on 04Jan2021 23:00. The patient had no covid prior vaccination, no covid tested post vaccination. No known allergies. The patient did not receive treatment for events. The event outcome of Fatigue and headache was not recovered.

Other Meds:

Current Illness:

ID: 0957373
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness at reaction site/ It was red/swollen; soreness at reaction site/ It was red/swollen; soreness at reaction site/ It was red/swollen; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as first single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced soreness at reaction site/ it was red/swollen on an unspecified date. Clinical details were as follows: After the 1st dose of the vaccine, the patient experienced soreness at reaction site only for 1-2 days then it went away; It was red and swollen. The patient kept rubbing it, and said that it was no big deal. The outcome of soreness at reaction site/ it was red/swollen was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .

Other Meds:

Current Illness:

ID: 0957374
Sex: F
Age:
State: KS

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site slight red and swollen for a day; Injection site slight red and swollen for a day; my taste was bitter. Then for the next 30 hours everything smelled and tasted like spoiled or rotting meat. Even water tasted rotten.; everything smelled and tasted like spoiled or rotting meat. Even water tasted rotten.; taste was bitter; This is a spontaneous report from a contactable Nurse (patient). This 47-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EK9231), on 07Jan2021 at 10:00 AM in right arm at single dose for COVID-19 immunisation. Age at vaccination was 47-years-old. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), on 17Dec2020 at 02:00 PM in left arm (age of vaccination was 46-years-old). Medical history included hypothyroidism. Known allergies included metoclopramide (REGLAN) and tramadol hydrochloride (ULTRAM). Concomitant medications were unknown. The patient was vaccinated at hospital. No other vaccine was received in four weeks. The second injection was given in the AM. By the afternoon on 07Jan2021 at 04:00 PM noted that her taste was bitter. Then for the next 30 hours everything smelled and tasted like spoiled or rotting meat. Even water tasted rotten. No fever or chills. Injection site slight red and swollen for a day, no joint pain, no body pain. Outcome was recovering. No treatment was received for the events.

Other Meds:

Current Illness:

ID: 0957375
Sex: F
Age:
State: MA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph node in left armpit with pain radiating down arm; Swollen lymph node in left armpit with pain radiating down arm; nerve pain in tips of right index and middle fingers intermittently and when touched; Swollen lymph node in left armpit with pain radiating down arm; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 08Jan2021 08:45 at single dose at left arm for COVID-19 immunization. Medical history included osteopenia, vitiligo, known allergies: Demerol and Vicodin. The patient's concomitant medication received in two weeks included Vitamins. The patient previously took the first dose of bnt162b2 intramuscularly on 18Dec2020 20:45 (lot number: EH9899) at single dose at right arm for COVID-19 immunization. Facility type vaccine was Hospital. No other vaccine received in four weeks. The patient experienced swollen lymph node in left armpit with pain radiating down arm; nerve pain in tips of right index and middle fingers intermittently and when touched on 09Jan2021 07:00. No treatment received for the events. No COVID prior vaccination. COVID test post vaccination: Nasal Swab Negative on 05Jan2021. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0957376
Sex: F
Age:
State: NY

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: myalgias; severe headache; rigors; low-grade fever; nausea; fatigue; This is a spontaneous report from a contactable Physician (patient). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscularly in right arm on 06Jan2021 11:30 at single dose for COVID-19 immunization. Facility type Vaccine: Hospital. Medical history included acne. Known allergies: No. Other medical history: none (on aldactone for acne). The patient was not pregnant. Concomitant medication in two weeks included spironolactone (ALDACTONE) for acne. The patient previously received the first dose of BNT162B2 (lot number EH9899) intramuscularly in right arm on 16Dec2020 11:30 for COVID-19 immunization. If other vaccine in four weeks: No. The patient experienced myalgias, severe headache, rigors, low-grade fever, nausea, fatigue 06Jan2021 15:00. The patient received treatment Ibuprofen and Acetominophen for the events. If Covid prior vaccination: No. If covid tested post vaccination: No. The outcome of all the events was recovered in Jan2021. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.

Other Meds: ALDACTONE

Current Illness:

ID: 0957377
Sex: F
Age:
State: NY

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Fever up to 100.5; Extreme fatigue; Muscle aches; Nausea; Lack of appetite; Immediate arm pain - swelling, tender to touch; Immediate arm pain - swelling, tender to touch; Immediate arm pain - swelling, tender to touch; This is a spontaneous report from a contactable Nurse. A 26-year-old female patient patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL3246) intramuscular, on 08Jan2021 at 16:00 on left arm at single dose for COVID-19 immunization. Relevant medical history included that patient had a Covid diagnosis on early October. Vaccination history included first dose of BNT162B2 (lot number: EK5730) on 18Dec2020 at 10:00 AM, Intramuscular on Left arm .Concomitant medication included ethinylestradiol, norethisterone acetate (JUNEL FE 1/20). The patient was not pregnant. On 08Jan2021 at 16:00 the patient experienced Immediate arm pain - swelling, tender to touch. On the same day at 22:00 the patient experienced Fever up to 100.5, extreme fatigue, muscle aches, nausea and lack of appetite. Treatment received included Tylenol. The patient recovered from Immediate arm pain - swelling, tender to touch on an unspecified date, from other reported events, recovered on 10Jan2021.

Other Meds: JUNEL FE 1/20

Current Illness:

ID: 0957378
Sex: F
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Crusty blood on her nose; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included anticoagulant therapy. Concomitant medications were not reported. The patient experienced crusty blood on her nose on an unspecified date with outcome of unknown. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957379
Sex: F
Age:
State: IN

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sudden onset severe muscle aches; Joint pain; Nausea; Lightheaded; Fever; Cold sweats; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient not pregnant received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 18Dec2020 08:15 AM as a single dose for COVID-19 immunization, lot number: EL0140. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications in two weeks prior to the vaccination included Multivitamins, Vitamin C, Vitamin D3, zinc oxide and fluticasone propionate (FLONASE). On 18Dec2020 04:00 PM patient experienced sudden onset severe muscle aches, joint pain, nausea, lightheaded, fever, cold sweats and fatigue. No treatment was received for the events. Patient recovered from all the events on unknown date in Jan2021. Patient had not been tested for COVID-19 post vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015086 same patient/vaccine, different dose/event

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D3; ; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 0957380
Sex: M
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain at injection site; high persistent fever; Chills; Nausea; Severe headache; Diffuse aches; This is a spontaneous report from a contactable physician (patient). A 28-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL1284), intramuscularly in the left arm, on 08Jan2021 at 16:45 (at the age of 28-years-old) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 22Dec2020 for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced pain at injection site, high persistent fever, chills, nausea, severe headache, and diffuse aches on 09Jan2021 at 06:00. The events were reported as non-serious. The events were reported to have started 12 hours after vaccination. The patient did not receive any treatment for the events. The clinical outcome of pain at injection site, high persistent fever, chills, nausea, severe headache, and diffuse aches was recovered in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0957381
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; fatigue; aches/soreness of the shot; shortness of breath; eyes hurting; swollen site; chills; fever; muscle pain; This is a spontaneous report from a contactable other HCP. A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number=EL1284 via an unspecified route of administration on 06Jan2021 13:00 at SINGLE DOSE for covid-19 immunisation dose number=2 vaccine location=Left arm facility type vaccine: Military Base. Medical history included diabetes mellitus, asthma, dry eye, blood cholesterol increased, rubber sensitivity Known allergies: Latex, food allergy: Nuts. Concomitant medication included lactobacillus reuteri (BIOGAIA), rosuvastatin calcium (CRESTOR), celecoxib (CELEXA [CELECOXIB]), sambucus nigra fruit (ELDERBERRY [SAMBUCUS NIGRA FRUIT]), metformin hydrochloride (GLUCOPHAGE XR) , benazepril hydrochloride (LOTENSIN [BENAZEPRIL HYDROCHLORIDE]), magnesium oxide (MAG-OX), omeprazole magnesium (PRILOSEC [OMEPRAZOLE MAGNESIUM]), ciclosporin (RESTASIS), montelukast sodium (SINGULAIR) , liraglutide (VICTOZA), ascorbic acid, bioflavonoids nos (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]), colecalciferol (VITAMIN D [COLECALCIFEROL]), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), zinc (ZINC). The patient previously took remeron and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, percocet [oxycodone hydrochloride;paracetamol] and experienced drug hypersensitivity. The first dose of BNT162B2 vaccine for covid-19 immunisation was done on 16Dec2020 08:30 Intramuscular at single dose, Vaccine location Left arm Dose number 1 Lot number=EK5730. On 06Jan2021 13:00 the patient experienced headache outcome of recovered, fatigue outcome of recovered, aches/soreness of the shot outcome of recovered, shortness of breath on 06Jan2021 13:00 with outcome of recovered, eyes hurting on 06Jan2021 13:00 with outcome of recovered, swollen site outcome of recovered, chills outcome of recovered, fever outcome of recovered, muscle pain outcome of recovered. The patient underwent lab tests and procedures which included sars-cov-2 test negative: negative on 06Aug2020. The action taken was not applicable.

Other Meds: BIOGAIA; CRESTOR; CELEXA [CELECOXIB]; ELDERBERRY [SAMBUCUS NIGRA FRUIT]; GLUCOPHAGE XR; LOTENSIN [BENAZEPRIL HYDROCHLORIDE]; MAG-OX; PRILOSEC [OMEPRAZOLE MAGNESIUM]; RESTASIS; SINGULAIR; VICTOZA; VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS];

Current Illness:

ID: 0957382
Sex: F
Age:
State: IL

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea; body aches; fatigue; severe headache; This is a spontaneous report from a contactable nurse (patient). This 35-year-old female patient (non-pregnant) received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730) on 18Dec2020 at 07:30 AM, in left arm, for COVID-19 immunisation. Medical history included seasonal allergies. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. Concomitant medications were not reported. About 4 hours after vaccination, on 18Dec2020 at 11:30 AM, the patient experienced nausea, body aches, fatigue and severe headache, all lasting 3-4 days. The events resolved on an unspecified date in Dec2020 without any treatment. COVID was not tested post vaccination. The second dose of BNT162B2 vaccine dose was given on 08Jan2021 at 14:30.

Other Meds:

Current Illness:

ID: 0957383
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscles aches; Fever up to 101.2 F; This is a spontaneous report from a contactable nurse reporting for herself. A 50-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EK9231), intramuscular, on 08Jan2021 at 06:45 AM, at single dose, for COVID-19 immunisation. Medical history included mild hypertension, Hashimoto's disease, gastrooesophageal reflux disease (GERD), insomnia. Patient did not have COVID-19 prior to vaccination. Concomitant medications included hydrochlorothiazide (unknown manufacturer), gabapentin (unknown manufacturer), acetylsalicylic acid (BABY ASPIRIN), omeprazole (PRILOSEC), trazodone (unknown manufacturer), cefixime (FLEXERIL), levothyroxine (unknown manufacturer), elderberry [sambucus nigra] (unknown manufacturer), vitamin c [ascorbic acid] (unknown manufacturer), colecalciferol (VITAMIN D). Previously the patient received the 1st dose of bnt162b2 (lot# EK5730), for immunisation, on 19Dec2020 at 03:30 PM, intramuscular in right arm. The patient experienced muscles aches on 09Jan2021 at 15:30 with outcome of recovered, fever up to 101.2 F on 09Jan2021 at 15:30 with outcome of recovered. The patient underwent lab tests and procedures which included body temperature: up to 101.2 F on 09Jan2021. Therapeutic measures were taken as a result of the events and included treatment with Tylenol. Patient was not tested for COVID-19 post vaccination.

Other Meds: ; ; BABY ASPIRIN; PRILOSEC; ; FLEXERIL; ; ELDERBERRY; VITAMIN C; VITAMIN D

Current Illness:

ID: 0957384
Sex: M
Age:
State: WV

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; high fever; achey; This is a spontaneous report from a contactable consumer (patient). A 27-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 at 14:00 at single dose in Left arm for COVID-19 immunization. Medical history included cystic fibrosis. No known allergy. The patient's concomitant medications were not reported. Patient previously, on an unknown date, received the first dose of the vaccine in Left arm for COVID-19 immunization.On 08Jan2021 at 22:00 the patient experienced vomiting, high fever and achey. No treatment given. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957385
Sex: F
Age:
State:

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive after 1st dose; tested positive after 1st dose; This is a spontaneous report from a contactable nurse reporting for herself. This nurse reported similar events for 2 patients: this is the first of two reports. This 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Dec2020 for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient tested positive after first dose. Outcome was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021021888 same reporter/drug/AE, different patient.

Other Meds:

Current Illness:

ID: 0957386
Sex: F
Age:
State: TX

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; extreme body/ muscle aches; extreme body/ muscle aches; headache; sore throat; I can't get out of bed; extremely tired; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Lot number EL3248), via an unspecified route of administration in the right arm on 09Jan2021 at single dose for COVID-19 immunisation. Medical history was none. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Lot number EK5730) on 19Dec2020 at 11:30 AM in the left arm. The patient's concomitant medications were not reported. On 09Jan2021 10:00 the patient experienced fever, extreme body/ muscle aches, headache, sore throat, can't get out of bed, extremely tired all with outcome of not recovered. The patient received no treatment due to the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0957387
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 01/06/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes on left collar bone area on neck; Neck muscle pain, left arm muscle pain near armpit; This is a spontaneous report from a non-contactable nurse(patient). A 26-year-old female patient received first dose BNT162B2( lot number EL1284) , via an unspecified route of administration at Arm Left on 29Dec2020 15:30 at the 26 years old at single dose for COVID-19 immunization. The medical history was none. There were not known allergies. The concomitant medication included fluoxetine hydrochloride(PROZAC). On 06Jan2021 the patient experienced Swollen lymph nodes on left collar bone area on neck, neck muscle pain, left arm muscle pain near armpit. There was no treatment received for the events. There was no other vaccine in four weeks. There was not covid prior vaccination. There was not covid tested post vaccination. The outcome of the events was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds: PROZAC

Current Illness:

ID: 0957388
Sex: M
Age:
State:

Vax Date: 12/28/2020
Onset Date: 01/04/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Between then and now I tested positive; Between then and now I tested positive; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 28Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated, "I have taken the vaccine (1st dose) on 28Dec2020 at the hospital. Between then and now I tested positive on the 04Jan2021, the hospital sent me home for 2 weeks. The 2nd part of the vaccine is coming up, it isn't until the 18Jan2021." The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957389
Sex: F
Age:
State: SC

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Myalgias; cephalgia; nausea; diarrhea; abdominal pain; Fatigue; first dose on 15Dec2020 15:30, second dose on 04Jan2021 16:00; first dose on 15Dec2020 15:30, second dose on 04Jan2021 16:00; This is a spontaneous report from a contactable physician (patient). A 31-year-old non-pregnant female patient receive second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL1284), via an unspecified route of administration on 04Jan2021 16:00 at single dose (Vaccine location: Left arm) for COVID-19 immunization. Medical history included Anxiety and Allergic Rhinitis. There were no known drug allergies. Historical Vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730) via an unspecified route of administration (Vaccine location: Left arm) on 15Dec2020 15:30 at single dose for COVID-19 immunization. There were no other vaccines received in four weeks. Concomitant medication included fexofenadine, sertraline. The patient did not have Covid-19 prior vaccination and did not have Covid-19 tested post vaccination. The patient experienced Myalgias, cephalgia, nausea, diarrhea, abdominal pain, fatigue on 05Jan2021 08:00. No treatment received for the reported events Myalgias, cephalgia, nausea, diarrhea, abdominal pain, fatigue. The outcome of the events Myalgias, cephalgia, nausea, diarrhea, abdominal pain, fatigue was recovered in Jan2021.

Other Meds: ;

Current Illness:

ID: 0957390
Sex: F
Age:
State: MN

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tmax (max temperature) 102; chills; muscle aches; headache; sharp shooting jaw pain; shooting into ears; This is a spontaneous report from a contactable nurse who reported for herself. A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EK 9231) second dose, via an unspecified route of administration on 07Jan2021 10:00 at single dose on right arm for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not have prior vaccination. Patient did not test COVID post vaccination. Patient had no known allergies. Historical vaccine included first dose of bnt162b2 (lot number EC 0140) on 21Dec2020 11:45 AM at single dose on right arm for COVID-19 immunisation. Patient experienced side effects included Tmax (max temperature) 102, chills, muscle aches, headache, sharp shooting jaw pain, shooting into ears, all on 07Jan2021 20:00 with outcome not resolved. It was unknown if patient received treatment for the events or not.

Other Meds:

Current Illness:

ID: 0957391
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I experienced chills; mild headache; fever ranging from 100.8 - 101.8; Mild body aches; This is Spontaneous report from a contactable consumer. A 64-year-old female consumer reported that she received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL0142), into the left arm on 08Jan2021 at 01:00 PM at single dose for COVID-19 immunization. The patient had a medical history of Rheumatoid Arthritis, Sjogren's Syndrome, Osteoarthritis and known allergies to penicillin, Valium, ketamine. Concomitant drug included Synthroid and Humira - Abbvie on 31Dec2020 (lot number 1136949). On 09Jan2021 approximately 24 hours after BNT162B2 administration, the patient experienced chills, mild headache and fever ranging from 100.8 - 101.8 and mild body aches. 48 hours later she still had fever ranging 100-101. No treatment was received. The patient did not have Covid prior vaccination and was not covid tested post vaccination. At the time of reporting the patient was recovering.

Other Meds: HUMIRA; SYNTHROID

Current Illness:

ID: 0957392
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it was given subcutaneously instead of intramuscularly; She reports that has a lump in her subcutaneous tissue where the vaccine was given; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was unknown), subcutaneously on 08Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient reported that she her second dose of the COVID-19 vaccine on Friday 08Jan2021 and she believes that it was given subcutaneously instead of intramuscularly. She reported that she has a lump in her subcutaneous tissue where the vaccine was given and this did not occur after the first dose was received. She was asking if she should be revaccinated. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957393
Sex: F
Age:
State: KS

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; aches; feeling faint; fatigue; This is a spontaneous report from a contactable Nurse (Patient). This 54-year-old female patient (No pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via Intramuscular on Left arm on 08Jan2021 15:00 at single dose (Lot EK9231) for covid-19 immunisation. No other vaccine in four weeks. Medical history included allergies: Sulfa, Augmentin. Concomitant medications included ciclosporin (RESTASIS, eye drops), mometasone furoate (FLONASE), boron, calcium, cimicifuga racemosa extract, folic acid, glycine max extract, magnolia officinalis, nicotinic acid, pyridoxine hydrochloride, riboflavin, selenium, thiamine, tocopherol, vitamin b12 nos (ESTROVEN), ipratropium and xylometazoline hydrochloride (NASAL SPRAY II). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular on Left arm on 17Dec2020 04:30 PM (Lot: VK5730) for covid-19 immunisation. The patient woke up 09Jan2021 at 7:00 am with fever (did not use thermometer) Aches, feeling faint, fatigue, took Advil and slept until 2pm, then took Tylenol and Felt better by 4pm. Outcome of the events was recovered.

Other Meds: RESTASIS; FLONASE; ESTROVEN; ; NASAL SPRAY II

Current Illness:

ID: 0957394
Sex: F
Age:
State: MO

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever as high as 101 F (now down to 97 F); body aches; chills; shaking; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for COVID-19 immunisation. Medical history included tested COVID positive from 27Dec2020. The patient's concomitant medications were not reported. Historical vaccine included first dose of vaccine on 17Dec2020. The patient started having symptoms on 23Dec2020 and tested COVID positive on 27Dec2020. Received the second dose of vaccine on 07Jan2021 and then was "having reaction to vaccine", experiencing the following: fever as high as 101 F (now down to 97 F), body aches, chills, shaking, "as I did when I had COVID". The patient said her coworkers are "experiencing the same things". Fever had resolved while the outcome of the remaining events was unknown. Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : -2021021949 Same patient/reporter/drug

Other Meds:

Current Illness:

ID: 0957395
Sex: F
Age:
State: NY

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; headache; fatigue; nausea; muscle aches; This is a spontaneous report from a contactable nurse reported for herself. This 19-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 09Jan2021 15:30 at single dose (vaccine location=left arm) for COVID-19 immunization. Medical history included allergies: Iodine, shellfish. The patient had COVID prior vaccination. Patient was not pregnant, and did not receive other vaccine in four weeks. The patient's concomitant medications were not reported. On 10Jan2021 07:00 AM, the patient experienced fever, headache, fatigue, nausea, muscle aches. No treatment received for events. Patient had not tested COVID post vaccination. The outcome of events was not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957396
Sex: F
Age:
State: KS

Vax Date: 12/17/2020
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: interrupt sleep throughout the night; mild body aches; lightheadedness; fatigue; slight headache; injection site soreness; Chills; fever; This is a spontaneous report from a contactable pharmacist (patient) and a contactable other health professional. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), on 17Dec2020 at 14:30 and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) on 08Jan2021 at 12:30, each via an unspecified route of administration at right arm at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medication included bupropion XL at 150 mg. On an unspecified date, the patient experienced 12 hrs. after vaccine administration, chills and subjective fever began and lasted approximately 24 hrs. (until 36 hrs. post-vaccine) severe enough to interrupt sleep throughout the night. Mild body aches during this time, along with lightheadedness, fatigue, slight headache and injection site soreness. The patient didn't receive any treatment. The patient outcome of the events was recovered.

Other Meds: BUPROPION XL

Current Illness:

ID: 0957397
Sex: F
Age:
State: MO

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; pretty severe muscle aches; This is a spontaneous report from Non-contactable consumer (patient) via. A 32-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, lot # EL1284) intramuscular at single dose on 06Jan2021 for Covid-19 immunisation. Medical history included drug hypersensitivity. The patient has not suffered from Covid prior vaccination. The patient was not pregnant at time of vaccination. The patient's concomitant medications were not reported. The patient experienced fatigue and pretty severe muscle aches on 07Jan2021. No treatment received. The outcome of recovered in Jan2021. Post-vaccination COVID tests were not performed. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0957398
Sex: F
Age:
State: WA

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection soreness; headache; tiredness/feeling rundown; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3249) on 20Dec2020 16:30 at single dose in left arm COVID-19 immunization. Medical history included Allergies to Sulfa, Factor IV Leiden, diabetes. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN), colecalciferol (VITAMIN D), lisinopril and Multivitamin (unspecified) . On 20Dec2020 at 20:00 the patient experienced injection soreness, headache, tiredness/feeling rundown. No treatment given and patient recovered from all the events on an unknown date. Patient was tested pot vaccination: a Nasal Swab was done on 29Dec2020 and was negative. On 09Jan2021 at 21:00 patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249) at single dose in Left arm for COVID-19 immunization.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015299 same patient, different event and vaccine

Other Meds: BABY ASPIRIN; VITAMIN D [COLECALCIFEROL];

Current Illness:

ID: 0957399
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lymphadenopathy near left side of clavicle, near injection site; This is a Spontaneous report from a contactable Consumer (patient). A 22-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on left arm on 09Jan2021 at 13:00 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient experienced lymphadenopathy near left side of clavicle, near injection site on 10Jan2021 at 13:00. The patient did not receive treatment for the event. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the event was not recovered. Information about Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957400
Sex: M
Age:
State: NJ

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Heartburn; Dose Number:1, Date of start of drug: 18Dec2020; Dose Number:2, Date of start of drug: 07Jan2021; Dose Number:1, Date of start of drug: 18Dec2020; Dose Number:2, Date of start of drug: 07Jan2021; This is a spontaneous report from a contactable physician (patient himself). A 59-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK9231), via an unspecified route of administration on 07Jan2021 08:30 in right arm at single dose for covid-19 immunisation. Other medical history included hypertension. The patient was known allergies: latex. Other medications in two weeks included nebivolol hydrochloride (BYSTOLIC). The patient previously took the first dose of BNT162B2 (lot# EJ1685) on 18Dec2020 03:00 PM in left arm for COVID-19 immunization. Facility type vaccine was in hospital. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient experienced heartburn on 08Jan2021 with outcome of not recovered. No treatment was received for heartburn.

Other Meds: BYSTOLIC

Current Illness:

ID: 0957401
Sex: M
Age:
State: CA

Vax Date: 01/03/2021
Onset Date: 01/05/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on abdomen; This is a spontaneous report from a contactable other healthcare professional (patient). A 43-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ELO-140), via an unspecified route of administration on left arm at 10:15 on 03Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. The patient's concomitant medications were not reported. The patient experienced rash on abdomen on 05Jan2021 at 08:00. The patient did not receive any treatment for event. The outcome of event was not recovered. The patient was not diagnosed COVID prior vaccination; The patient had not COVID tested post vaccination.

Other Meds:

Current Illness:

ID: 0957402
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy almost everywhere; palms very pink and can see tiny vessels (petechia); palms very pink and can see tiny vessels (petechia); feels like a lot of blood to extremities - warm and tingly; feels like a lot of blood to extremities - warm and tingly; huge rashes on bilateral abdomen and neck.; This is a spontaneous report from a contactable consumer (patient). This 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 05Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced huge rashes on bilateral abdomen and neck on 08Jan2021 and itchy almost everywhere, palms very pink and can see tiny vessels (petechia), and feels like a lot of blood to extremities - warm and tingly on 10Jan2021. The events were reported as non-serious. The clinical course was reported as follows: The patient received the first dose of vaccine on 05Jan2021 and three days later, on 08Jan2021, noticed huge rashes on bilateral abdomen and neck. The rash was noticed after shower and went away after about an hour and a half (as reported). The patient woke up on 10Jan2021, itchy almost everywhere. The palms were very pink and can see tiny vessels (petechia). It was reported to have felt like when you go for a run and feel like you get a lot of blood to your extremities - warm and tingly (as reported). The patient was seen at an urgent care and did a blood test, on an unspecified date, with results still pending (unknown results). The clinical outcome of huge rashes on bilateral abdomen and neck was recovered in Jan2021 and of itchy almost everywhere, palms very pink and can see tiny vessels (petechia), and feels like a lot of blood to extremities - warm and tingly was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.

Other Meds:

Current Illness:

ID: 0957403
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever of 101; chills; This is a spontaneous report from a contactable consumer and nurse. A 59-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunization. The patient experienced a fever of 101 and chills on an unspecified date. The patient underwent lab tests and procedures which included body temperature: 101 on an unspecified date. The clinical outcome of fever of 101 and chills was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 0957404
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; chills; lightheaded; muscle aches; joint pain; diarrhea; lethargy; This is a spontaneous report from a contactable nurse. A 40-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, expiry date not reported), intramuscular in the left arm on 08Jan2021 12:00 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient previously took first dose of bnt162b2 (lot number: EK5730, expiry date not reported), intramuscular in the left arm on 18Dec2020 12:00 at single dose for COVID-19 immunisation. The patient previously took cefalexin (KEFLEX), clindamycin and codeine and experienced drug allergies. On 09Jan2021 12:00, the patient experienced fever, chills, was lightheaded, muscle aches, joint pain, diarrhea and lethargy. No treatment was received for the adverse events. Clinical outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0957405
Sex: M
Age:
State: WA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; chills; sweating; nausea; elevated BP; pale face; fatigue; loss of appetite; This is a spontaneous report from a contactable Other HCP. A 32-year-old male patient reported that he received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL1283), at single dose on 09Jan2021 at 03:30 PM for COVID-19 immunization. The patient had received first dose of BNT162B2 (lot number: EJ1685) on 19Dec2020. O n 12Dec2020 the patient was Covid tested via Nasal Swab COVID-19 PCR and the result was negative. On 10Jan2021 at 12:30 PM the patient experienced fever, chills, sweating, nausea, elevated BP, pale face, fatigue, loss of appetite. No treatment was received. The patient did not have Covid prior vaccination. At the time of reporting the patient had not recovered.

Other Meds:

Current Illness:

ID: 0957406
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had fever up to 100.4; chills; body aches; This is a spontaneous report from a contactable physician. A 48-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular 09Jan2021 10:00 am in left arm at single dose for covid-19 immunisation. The patient medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient previously took the first dose of BNT162B2 for COVID-19 immunization. Facility type vaccine was in hospital. Other medications in two weeks was none. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient had fever up to 100.4, chills, body aches on 10Jan2021 09:00 AM. No treatment was received for the events. Outcome of events were recovering. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0957407
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; muscle aches; fatigue; a fever of 103 F; currently breastfeeding mother received the vaccine; currently breastfeeding mother received the vaccine; This is a spontaneous report from a contactable nurse. This nurse reported information for both mother and baby. This is the maternal case. A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the right arm, on 08Jan2021 at 05:45 (at the age of 32-years-old) at a single dose for COVID-19 immunization. Medical history included hypertension, non-ongoing COVID-19 from Apr2020 to an unspecified date (1.5 weeks with symptoms at 28 weeks pregnant; recovered), and breastfeeding from an unspecified date and ongoing. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications, taken within two weeks of vaccination, included labetalol (MANUFACTURER UNKNOWN) and an unspecified postnatal vitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced chills, muscle aches, fatigue, and a fever of 103 F on 08Jan2021 at 19:00. The events were reported as non-serious. The currently breastfeeding mother received the vaccine on 08Jan2021 at 05:45. The clinical course was reported as follows: Approximately 12 hours (as reported) after the vaccine, the patient developed chills, muscle aches, fatigue, and a fever and body temperature of 103 F on 08Jan2021 at 19:00. The patient was treated with an unspecified antipyretic and the fever and body temperature spiked to 103 F again during the night. The next day (24-48 hours post vaccine), the patient had a fever and body temperature of 100-101.7 F on 09Jan2021, intermittently while treating with ibuprofen (MANUFACTURER UNKNOWN). The chills were not as bad as before, but body aches and fatigue were still present. On 10Jan2021, over 48 hours post-vaccine, the patient felt mostly fatigued with body temperature of 99 F. At 13:00 on 10Jan2021, the fever came back at body temperature of 101.6 F, which was treated with ibuprofen. Therapeutic measures were taken as a result of chills, muscle aches, fatigue, and a fever of 103 F as aforementioned. The clinical outcome of chills, muscle aches, fatigue, and a fever of 103 F was recovering and of currently breastfeeding mother received the vaccine was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021022120 same reporter, different patient/event (baby case)

Other Meds:

Current Illness: Breast feeding

ID: 0957408
Sex: F
Age:
State: SD

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Fever; Chills; Muscle ache; Feeling nauseous; This is a spontaneous report from a non-contactable consumer (parent of the patient). A female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 06:30 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, fever, chills, muscle ache, on an unspecified date. These symptoms were gone on unspecified date. On unspecified date the patient has been feeling nauseous all day, with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0957409
Sex: M
Age:
State: NY

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: R axillary tenderness/lymphadenopathy persisting, now 2 weeks post vaccination; R axillary tenderness/lymphadenopathy persisting, now 2 weeks post vaccination; This is a spontaneous report from a contactable Physician (patient). A 47-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 28Dec2020 12:00 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced r axillary tenderness/lymphadenopathy persisting, now 2 weeks post vaccination on 29Dec2020 with outcome of recovering. The patient was not treated due to the events. The patient underwent nasal swab covid test on 04Jan2021 and was negative. The patient did not experienced covid prior to vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957410
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: just doesn't feel well; high blood pressure; feels like throwing up; This is a spontaneous report from a contactable consumer (patient) received via Medical Information Team. A 48-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced "having some high blood pressure", she "feels like throwing up" and "she doesn't feel well". The patient outcome of the events was unknown. The information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0957411
Sex: F
Age:
State: NJ

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Full body myalgia; fatigue; diaphoresis; fever; Left upper arm edema and pain/tenderness.; Left upper arm edema and pain/tenderness.; This is a spontaneous report from a contactable nurse reported for herself. A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EK9231 via an unspecified route of administration on 09Jan2021 11:00 at SINGLE DOSE for covid-19 immunisation. Vaccine location: left arm, dose number 2, facility type vaccine: hospital. Historical Vaccine bnt162b2 (BNT162B2) Lot number EL0140 on 21Dec2020 14:45 vaccine location left arm, dose number 1, facility type vaccine: hospital. The patient medical history was not reported. There were no concomitant medications. The patient experienced left upper arm edema and pain/tenderness onset within 3 hours of receiving the 2nd dose of the vaccine. In addition: full body myalgia, fatigue, diaphoresis and fever. Symptom duration was about 12 hours. Symptoms were relieve with Tylenol and Ibuprofen. The action taken was not applicable.

Other Meds:

Current Illness:

ID: 0957412
Sex: F
Age:
State: IL

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash temp of 101; Rash temp of 101; body aches; This is a spontaneous report from a contactable other health professional. This report involves a 33-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose in the left arm on 09Jan2021 10:45 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown dose for covid-19 immunisation. On 10Jan2021, the patient experienced rash, temp of 101, body aches with outcome of recovering. The vaccine was administered at Hospital Facility. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0957413
Sex: F
Age:
State: TX

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Right sided cervical lymphadenopathy; 1st dose administration date: 22Dec2020; 2nd dose administration date: 09Jan2021; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 29-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, on 22Dec2020 at 06:45 (lot number: EK5730) at 29 years of age and the second dose on 09Jan2021 at 11:00 (Lot number: EL3248), at 29 years of age, both via an unspecified route of administration in right arm, at single dose for COVID-19 immunization. The patient was vaccinated at facility hospital and was not pregnant when she received the vaccine. Medical history included hypothyroidism and rhinitis allergic, both from an unknown date. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE 1.5/30), fluticasone propionate (FLONASE), levothyroxine sodium (SYNTHROID) and cetirizine hydrochloride (ZYRTEC). On 10Jan2021 the patient experienced right sided cervical lymphadenopathy, in deep anterior chain, under right sternocleidomastoid (SCM) muscle, tender to palpation, assessed as non-serious. No treatment was administered to the patient for the reported event. The patient was tested for Covid twice: once in Jul2020 via blood test (SARS COV-2 Antibody) and once in Nov2020 via nasal swab (test name: Sofia Rapid COVID antigen test) and both tests had negative result. At the time of the report the event was recovering.

Other Meds: BLISOVI FE 1.5/30; FLONASE [FLUTICASONE PROPIONATE]; SYNTHROID; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0957414
Sex: F
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 05Jan2021 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN), hyperlipidaemia (HLD) and arthritis from. The patient's concomitant medications included adalimumab (HUMIRA). The patient received her first dose of Pfizer Biontech Covid 19 vaccine on05Jan2021. She began feeling symptoms on 06Jan2021. She reported the following: swollen lips and tongue, redness on tongue and inside of lips. On 07Jan2021, the symptoms persisted, and the patient took Benadryl and Claritin. Her symptoms were still present at the time of report. She would like to know if she should get the second dose. And if there was any literature available for patients who take Humira and receive the vaccine. Information on the lot/batch number has been requested.

Other Meds: HUMIRA

Current Illness:

ID: 0957415
Sex: M
Age:
State:

Vax Date: 12/20/2020
Onset Date:
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My left arm is sore, where the injection site was, near my armpit, the flank below my breast - that area is considerably more swollen than the other; My left arm is sore, where the injection site was, near my armpit, the flank below my breast - that area is considerably more swollen than the other; My left arm is sore, where the injection site was, near my armpit, the flank below my breast - that area is considerably more swollen than the other; This is a spontaneous report from a contactable other health professional. A male patient of an unspecified age (Age: 43; Unit: Unknown) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 20Dec2020 at a single dose on left arm, and the second dose via an unspecified route of administration on 08Jan2021 10:30 at a single dose on left arm, both for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported: "got second dose 08Jan2021 at 10:30 am, first dose on 20Dec2020. My left arm is sore, where the injection site was, near my armpit, the flank below my breast - that area is considerably more swollen than the other." The outcome of the events was unknown. The events were assessed as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0957416
Sex: F
Age:
State: TX

Vax Date: 12/16/2020
Onset Date: 12/22/2020
Rec V Date: 01/20/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hypertensive Emergency (BP 219/114) with no previous blood pressure issues; Radiating chest pain, left arm pain; jaw pain; This is a spontaneous report from a contactable other Health Professional (patient). A 40-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EX5170), via an unspecified route of administration on 16Dec2020 15:00 at single dose in left arm for covid-19 immunization. Medical history included symptomatic PVC's (Premature ventricular contractions), tachycardia, bradycardia, CVA (cerebrovascular accident) from 2018 to an unknown date, asthma and rhythm. Concomitant medication included flecainide, spironolactone, metoprolol for rhythm. The patient had known allergies included hydrocodone bitartrate, paracetamol (VICODIN), eletriptan and adhesive. Prior vaccination, the patient had no covid. On 22Dec2020 18:00, the patient experienced hypertensive Emergency (BP 219/114) with no previous blood pressure issues. Radiating chest pain, left arm pain, and jaw pain. Admitted to the hospital where an echocardiogram and angiogram was performed showing clear coronary arteries and no hypertensive remodeling of the heart. Issue has been ongoing since, despite interventions. The events result in emergency room/department or urgent care and hospitalization from an unspecified date for 1 day. The patient received the treatment for the events included frequent nitroglycerin, hydralazine and metoprolol. The patient underwent curative-SARS-Cov-2 Assay RT-PCR on 01Jan2021 with negative result. The outcome of the events was not recovered.; Sender's Comments: Based on the information available, contributory role of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE,) to event "hypertensive emergency (BP 219/114) with no previous blood pressure issues" cannot be excluded. The events chest pain and pain in jaw are attributed to underlying medical conditions and assessed unrelated. BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE,). The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ; ;

Current Illness:

ID: 0957417
Sex: F
Age:
State: TX

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/20/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever every 3 hours; I got a rash; Vomiting; Very Bad Headache; Joint pain; Fatigue; Pain in Injection site; Lymph nodes swelling and pain; Lymph nodes swilling and pain; received the first dose on 18Dec2020 and the second dose on 06Jan2021; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 32-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3746), via an unspecified route of administration on the left arm on 06Jan2021 at a single dose for COVID-19 immunization. There were no medical history and no concomitant medications. The patient has no known allergies. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) on the left arm on 18Dec2020 at 07:30 at a single dose as COVID-19 immunization. The patient had no other vaccine in four weeks, no COVID prior vaccination, and did not test post-vaccination. The patient had a rash, high fever every 3 hours, vomiting, very bad headache, joint pain, fatigue, pain in injection side, lymph nodes swelling and pain on 08Jan2021 at 12:00. No treatment was administered for the events. The events were resolving.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm